Anti-N-methyl-D-aspartate receptor encephalitis associated with hepatic neuroendocrine carcinoma: A case report
1National Neuroscience Institute, Singapore General Hospital Campus, 20 College Road, Academia 169856, Singapore.
Abstract:
Anti-N-methyl-D-aspartate receptor (Anti-NMDAR) encephalitis can present with and without tumor. Tumor associations are less common in older patients. We report a 65-year-old gentleman who presented with one week history of cough, chills, rigor and altered behavior, followed by florid visual and auditory hallucinations. Mini mental status examination score was 16/30. Both cerebrospinal fluid and plasma anti-NMDA receptor antibodies were detected. A course of intravenous methylprednisolone was given with partial symptom improvement. A hepatic neuroendocrine carcinoma was detected and confirmed on biopsy. Unfortunately, he developed several medical complications: non-ST elevation myocardial infarction, infected foot gangrene and peripheral vascular disease, which made him unsuitable for both surgery and chemotherapy. He passed away 6months later due to the progression of the malignancy. This case illustrated that NMDAR encephalitis may be associated with an uncommon hepatic neuroendocrine carcinoma in an older person, which is responsive to early treatment.
Insights
This case report highlights anti-N-methyl-D-aspartate receptor (Anti-NMDAR) encephalitis in an older male associated with a rare hepatic neuroendocrine carcinoma. Early treatment showed partial symptom improvement, emphasizing the importance of considering this diagnosis in elderly patients.
Area of Science:
- Neurology
- Oncology
Background:
- Anti-N-methyl-D-aspartate receptor (Anti-NMDAR) encephalitis is an autoimmune disorder.
- Tumor association is less frequent in older individuals with Anti-NMDAR encephalitis.
Observation:
- A 65-year-old male presented with symptoms of Anti-NMDAR encephalitis, including altered behavior and hallucinations.
- Cerebrospinal fluid and plasma tests confirmed the presence of anti-NMDA receptor antibodies.
- A hepatic neuroendocrine carcinoma was diagnosed in the patient.
Findings:
- The patient received intravenous methylprednisolone, resulting in partial symptom improvement.
- The co-occurrence of Anti-NMDAR encephalitis and hepatic neuroendocrine carcinoma in an elderly patient is rare.
- The patient's advanced age and comorbidities precluded surgical or chemotherapeutic interventions.
Implications:
- This case underscores the possibility of Anti-NMDAR encephalitis associated with uncommon tumors like hepatic neuroendocrine carcinoma in older adults.
- Early diagnosis and treatment of Anti-NMDAR encephalitis can lead to partial symptom recovery, even in the presence of malignancy.
- Further research is needed to understand the specific mechanisms and management strategies for paraneoplastic NMDAR encephalitis in the elderly population.
More Related Videos
08:55Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
Published on: April 15, 2016
07:20A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood
Published on: January 9, 2018
Related Concept Videos
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Hepatic Encephalopathy
